| Identification | Back Directory | [Name]
3-BROMOIMIDAZO[1,2-B]PYRIDAZINE | [CAS]
18087-73-5 | [Synonyms]
Ponatinib Impurity 2
Ponatinib intermediate
3-BroMoiMidazo[1,2-b]pyri...
3-broMoiMidazo(1,2-b)pyridazin
3-BROMOIMIDAZO[1,2-B]PYRIDAZINE
IMidazo[1,2-b]pyridazine, 3-broMo-
3-Bromoimidazo[1,2-b]pyridazine >
3-Bromoimidazo[1,2-b]pyridazine
3-BROMOIMIDAZO[1,2-B]PYRIDAZINE 18087-73-5
3-BROMOIMIDAZO[1,2-B]PYRIDAZINE ISO 9001：2015 REACH | [Molecular Formula]
C6H4BrN3 | [MDL Number]
MFCD09757672 | [MOL File]
18087-73-5.mol | [Molecular Weight]
198.03 |
| Chemical Properties | Back Directory | [Melting point ]
148.0 to 152.0 °C | [density ]
1.89 | [storage temp. ]
Keep in dark place,Sealed in dry,Room Temperature | [form ]
powder to crystal | [pka]
2.35±0.30(Predicted) | [color ]
White to Light yellow | [CAS DataBase Reference]
18087-73-5 |
| Hazard Information | Back Directory | [Uses]
3-Bromoimidazo[1,2-B]pyridazine is a pharmaceutical intermediate compound. It is used in the preparation of Ponatinib, a tyrosine kinase inhibitor (TKI), which is used in the treatment of chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). |
|
|